Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dual sEH/COX-2 Inhibition Using PTUPB—A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity

Frontiers in Pharmacology(2021)10.3389/fphar.2021.744776Source: DataRank Database

Dual sEH/COX-2 Inhibition Using PTUPB—A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity is a research paper published in Frontiers in Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (32)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Scott D. Barnett ORCID,Anna Stavniichuk,Sung Hee Hwang ORCID,Bruce D. Hammock ORCID,Jawad Bin Belayet ORCID

Live enrichment

PubMed:34955823 PMC:PMC8695932

NIEHS NIH HHS

Grant: R35 ES030443

NIEHS NIH HHS

Grant: P42 ES004699

National Institutes of Health

Grant: 5R01DK103616-03

Eicosanoid-based Therapy for Diabetes

National Institutes of Health

Grant: 5R35ES030443-04

Bioactive lipids as effectors and indicators of the deleterious effects of environmental exposure on chronic diseases

National Institutes of Health

Grant: 5P42ES004699-30

Biomarkers of Exposure to Hazardous Substances

National Institutes of Health

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2021.744776/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2021.744776/full

repositoryhttps://doaj.org/article/e8f82b4b18574d1a9c54c00e6d649b7a

repositoryhttps://escholarship.org/uc/item/4sw600cn

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8695932

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciences

Keywords

NephrotoxicityVascular Endothelial Growth FactorEicosanoidsKidney InjurySoluble Epoxide Hydrolase (Seh)Cyclooxygenase (Cox)Glomerular InjuryMultitarget DrugsKidney DiseaseClinical Sciences610RM1-950soluble epoxide hydrolaseCardiovascular5.1 Pharmaceuticals (hrcs-rac)32 Biomedical and Clinical Sciences (for-2020)Hypertension (rcdc)Kidney Disease (rcdc)3202 Clinical Sciences (for-2020)PharmacologyBiomedical and Clinical Sciences1115 Pharmacology and Pharmaceutical Sciences (for)Pharmacology and Pharmaceutical Sciencescyclooxygenase5.1 PharmaceuticalsHypertensionCardiovascular (rcdc)Therapeutics. Pharmacology3214 Pharmacology and pharmaceutical sciences (for-2020)

Sustainable Development Goals

SDG 3: 3. Good health

Dual sEH/COX-2 Inhibition Using PTUPB—A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity

FAIR Checklist

Authors (8)

Funding (6 grants)

Open Access

Topics

Annotations (Europe PMC)